Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Pharmacometrics to characterize pharmacokinetics and optimize treatment in understudied populations
Clinical trials frequently exhibit a lack of participant diversity, with underrepresentation of certain demographics, including pregnant women, individuals at the extremes of age (such as children or the elderly), and specific racial or ethnic groups (such as people of African ancestry). Consequentl...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English English |
| Published: |
Division of Clinical Pharmacology
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Pharmacometrics to characterize pharmacokinetics and optimize treatment in understudied populations
- Addressing challenges in the treatment of tuberculosis and tuberculosis meningitis: a pharmacometric approach
- Advancing tuberculosis treatment through pharmacometric modeling of drug exposure and biomarkers
- Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment
- Population pharmacokinetic modelling for dose optimization of esomeprazole to treat early-onset preeclampsia
- Pharmacokinetics of propofol in cats
- Aspects of the pharmacokinetics of hypoxoside in rodents